Lhss prepared this report, discussing procurement and payment considerations related to the transition of first-line tuberculosis (TB) drug procurement in Vietnam from the central state budget to the social health insurance fund starting in 2022.

Conducted by LHSS, this market analysis examines four factors affecting SHI-covered ARV procurement and supply in Vietnam, and it also summarizes findings and recommendations across each of these factors.

This report presents findings and recommendations from a September-October 2021 assessment of how health facilities were using the ventilators.

It summarizes the draft strategy’s recommendations for strengthening Uzbekistan’s infectious disease surveillance and rapid response system.

This document provides a roadmap for Vietnam’s National Tuberculosis (TB) Program to transition procurement and payment for TB drugs to the country’s social health insurance scheme.

This report summarizes the results of a review of international experience and best practices related to pro-health excise taxes.

LHSS in this report recommends that the government raise pro-health excise taxes at greater rates than currently proposed by the Ministry of Finance in order to increase the revenue raised.

For the first time, Vietnam has procured TB medicines using its national social health insurance scheme. 

This video captures a November 6, 2020 ceremony in Hanoi which marked the formal start of the LHSS Project’s four-year effort to help the Government of Vietnam implement its social health insurance program. The program covers treatment services for people with HIV, among other essential health services.

Working closely with the Vietnam Social Security (VSS) agency, LHSS will help improve the agency’s capacity to manage the insurance program funds effectively, efficiently, equitably, and with accountability. LHSS will also support Vietnam’s transition to full financial ownership of its HIV and TB responses.

HMED software will improve Vietnam’s capacity to effectively forecast ARV demand, and manage the drugs when they are in the country. Also, engaging drug manufacturers and distributors is crucial to overcoming supply side obstacles.

On December 17, 2021, the U.S. Agency for International Development (USAID) held a capstone event in Tashkent, Uzbekistan to mark the achievements made by its Local Health System Sustainability (LHHS) COVID-19 response activity. This video is a recording of that event which was organized as a hybrid event in which the majority of attendees participated virtually.

This Google Play App is a distance learning platform for training on the use of mechanical ventilation. It was developed in coordination with the Government of Uzbekistan and continues to be used to train health providers caring for severe cases of COVID-19.

LHSS supported a coordinated national emergency response led by the Ministry of Health and helped build the resilience of the health system against future shocks in Uzbekistan.